as on September 4, 2025 at 1:29 am IST
Day's Low
Day's High
1.23%
Downside
0.80%
Upside
52 Week's Low
52 Week's High
10.77%
Downside
19.48%
Upside
Check Amgen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$154.5B
EPS (TTM)
21.0734
Dividend Yield
2.63%
Quarterly Earnings Growth YOY
0.92%
PE Ratio (TTM)
23.48
Industry PE ratio
15.08
P/B Ratio
23.4795
PEG Ratio
0.924
EBITDA
16.1B
Revenue (TTM)
34.9B
Profit Margin
18.96%
Return On Equity TTM
99.14%
Track how Amgen Inc. P/E has moved over time to understand its valuation trends.
Amgen Inc. in the last 5 years
Lowest (12.34x)
December 31, 2021
Industry (15.08x)
September 3, 2025
Today (23.48x)
September 3, 2025
Highest (17.02x)
September 30, 2024
Today’s Price to Earnings Ratio: 23.48x
Compare market cap, revenue, PE, and other key metrics of Amgen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $154.5B | 16.05% | 23.48 | 18.96% | |
BUY | $659.1B | 391.6% | 48.02 | 25.91% | |
BUY | $374.4B | 129.02% | 100.91 | 6.45% | |
BUY | $248.7B | 73.51% | 14.51 | 35.61% | |
BUY | $428.8B | 18.47% | 19.04 | 25.00% |
The Amgen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amgen Inc. investment value today
Current value as on today
₹90,805
Returns
Returns from Amgen Inc. Stock
Dollar Returns*
₹4,919 (+4.92%)
Based on 37 analysts
56.76%
Buy
35.14%
Hold
8.11%
Sell
Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc.. Average target price of $311.88
Get share price movements and forecasts by analysts on Amgen Inc..
What analysts predicted
8.98%UPSIDE
Target Price
$311.88
Current Price
$283.86
Analyzed by
37 Analysts
Target
$311.88
Amgen Inc. target price $311.88, a slight upside of 8.98% compared to current price of $283.86. According to 37 analysts rating.
Investment in Amgen Inc. Shares on INDmoney has grown by 21.73% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:21.73% versus previous 30 day period
Search interest for Amgen Inc. Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Check out the Mutual Funds with significant holdings in Amgen Inc..
Today's Timeline - 28 August
Thu, 10:09 AM
-Amgen reports $155 billion market cap and 14.6% annual revenue growth, with strong free cash flow margin of 29.8%.
Thu, 12:36 PM
-Leerink Partners maintains a Hold rating on Amgen, citing growth potential for Repatha but significant long-term risks.
Thu, 04:41 PM
-Veeva Systems collaborates with Amgen to enhance clinical trial efficiency using the Veeva Clinical Platform.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Amgen Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $8.14 billion to $9.16 billion, which represents an average increase of 11.1% per quarter.
Against Peers
In the last 3 years, Eli Lilly And Company has given 55.5% return, outperforming this stock by 37.2%
Against Peers
In the last 1 year, Abbvie Inc has given 7.2% return, outperforming this stock by 20.4%
Profit Down
Amgen Inc. has experienced a decline in its net profit over the last two quarters. Specifically, the net profit decreased from $1.73 billion to $1.43 billion. This represents an average decrease of 17.2% per quarter.
Price Dip
In the last 1 month, AMGN stock has moved down by -3.4%
Organisation | Amgen Inc. |
Headquarters | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
Industry | Health Technology |
CEO | Mr. Robert A. Bradway |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. David M. Reese M.D. | Executive VP & CTO |
Mr. Murdo Gordon | Executive Vice President of Global Commercial Operations |
Dr. James E. Bradner M.D. | Executive Vice President of Research & Development |
Mr. Matthew C. Busch | Chief Accounting Officer & VP of Finance |
Mr. Howard Y. Chang M.D., Ph.D. | Senior VP of Global Research & Chief Scientific Officer |
Mr. Robert A. Bradway | Chairman, CEO & President |
Mr. Peter H. Griffith | Executive VP & CFO |
Mr. Esteban Santos | Executive Vice President of Operations |
Mr. Scott Skellenger | Senior VP & Chief Information Officer |
Justin G. Claeys | Vice President of Investor Relations |
Amgen Inc. share price today is $283.86 as on at the close of the market. Amgen Inc. share today touched a day high of $286.12 and a low of $280.38.
Amgen Inc. share touched a 52 week high of $339.17 on and a 52 week low of $253.3 on . Amgen Inc. stock price today i.e. is closed at $283.86,which is 16.31% down from its 52 week high and 12.06% up from its 52 week low.
Amgen Inc. market capitalisation is $0.15T as on .
Indian investors can start investing in Amgen Inc. (AMGN) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Amgen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amgen Inc. share’s latest price of $283.86 as on September 4, 2025 at 1:29 am IST, you will get 0.0352 shares of Amgen Inc.. Learn more about
fractional shares .
Amgen Inc. stock has given 16.05% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?